Sarah Swerdlow

516 total citations
10 papers, 386 citations indexed

About

Sarah Swerdlow is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Sarah Swerdlow has authored 10 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Sarah Swerdlow's work include Autophagy in Disease and Therapy (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Sarah Swerdlow is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Sarah Swerdlow collaborates with scholars based in United States. Sarah Swerdlow's co-authors include Shaoguang Li, Francis Y. Lee, Yiguo Hu, Roberto Weinmann, Theodore M. Duffy, Clark Distelhorst, Minh Lam, Karen McColl, Terri H. Finkel and Mieko Matsuyama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Sarah Swerdlow

10 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Swerdlow United States 5 189 172 110 60 60 10 386
Hardik Modi United States 10 351 1.9× 223 1.3× 222 2.0× 64 1.1× 98 1.6× 17 588
Giuseppina Fugazza Italy 13 330 1.7× 230 1.3× 226 2.1× 22 0.4× 83 1.4× 36 599
Marisa Pautasso Italy 12 262 1.4× 264 1.5× 187 1.7× 31 0.5× 33 0.6× 35 584
Martin Kirschner Germany 13 134 0.7× 196 1.1× 105 1.0× 20 0.3× 50 0.8× 33 389
Jean‐Loup Huret France 6 99 0.5× 165 1.0× 92 0.8× 16 0.3× 32 0.5× 13 348
L.R. Silverman United States 9 325 1.7× 207 1.2× 160 1.5× 65 1.1× 26 0.4× 18 492
Olga Haus Poland 14 144 0.8× 236 1.4× 65 0.6× 9 0.1× 36 0.6× 85 528
Ashwini Yenamandra United States 9 100 0.5× 363 2.1× 46 0.4× 27 0.5× 18 0.3× 21 523
Masuzu Ueda Japan 8 227 1.2× 191 1.1× 128 1.2× 9 0.1× 26 0.4× 19 410
Paula de Melo Campos Brazil 11 168 0.9× 147 0.9× 83 0.8× 9 0.1× 30 0.5× 43 353

Countries citing papers authored by Sarah Swerdlow

Since Specialization
Citations

This map shows the geographic impact of Sarah Swerdlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Swerdlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Swerdlow more than expected).

Fields of papers citing papers by Sarah Swerdlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Swerdlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Swerdlow. The network helps show where Sarah Swerdlow may publish in the future.

Co-authorship network of co-authors of Sarah Swerdlow

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Swerdlow. A scholar is included among the top collaborators of Sarah Swerdlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Swerdlow. Sarah Swerdlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Swerdlow, Sarah, et al.. (2024). Swi/Snf chromatin remodeling regulates transcriptional interference and gene repression. Molecular Cell. 84(16). 3080–3097.e9. 4 indexed citations
2.
Swerdlow, Sarah, et al.. (2021). Transitioning Cell Culture CURE Labs from Campus to Online: Novel Strategies for a Novel Time . Journal of Microbiology and Biology Education. 22(1). 1 indexed citations
3.
Swerdlow, Sarah & Roel M. Schaaper. (2014). Mutagenesis in the lacI gene target of E. coli: Improved analysis for lacId and lacO mutants. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 770. 79–84. 8 indexed citations
4.
Molitoris, Jason K., Karen McColl, Sarah Swerdlow, et al.. (2011). Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in Lymphocytes. Journal of Biological Chemistry. 286(34). 30181–30189. 73 indexed citations
5.
Molitoris, Jason K., Karen McColl, Sarah Swerdlow, et al.. (2011). Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes.. Journal of Biological Chemistry. 286(45). 39673–39673. 2 indexed citations
6.
Swerdlow, Sarah, Karen McColl, Yiping Rong, et al.. (2008). Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes. Autophagy. 4(5). 612–620. 48 indexed citations
7.
Swerdlow, Sarah & Clark Distelhorst. (2007). Bcl-2-Regulated Calcium Signals as Common Mediators of Both Apoptosis and Autophagy. Developmental Cell. 12(2). 178–179. 31 indexed citations
8.
Hu, Yiguo, Sarah Swerdlow, Theodore M. Duffy, et al.. (2006). Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph + leukemia in mice. Proceedings of the National Academy of Sciences. 103(45). 16870–16875. 214 indexed citations
10.
Li, Shaoguang, Yiguo Hu, Sarah Swerdlow, & Francis Y. Lee. (2004). Simultaneous Targeting of SRC and BCR-ABL Kinases by BMS-354825 Cures Ph+ Acute Lymphoblastic Leukemia in Mice.. Blood. 104(11). 1976–1976. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026